Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies - Revenue Recognition (Details)

v3.24.1
Significant Accounting Policies - Revenue Recognition (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Significant Accounting Policies    
Revenue $ 1,266,375 $ 1,049,471
Capitated revenue    
Significant Accounting Policies    
Revenue $ 1,252,309 $ 1,034,800
Capitated revenue | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 99.00% 99.00%
Total other patient service revenue    
Significant Accounting Policies    
Revenue $ 14,066 $ 14,671
Total other patient service revenue | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 1.00% 1.00%
Clinical fees & insurance revenue    
Significant Accounting Policies    
Revenue $ 5,192 $ 6,158
Clinical fees & insurance revenue | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 0.00% 0.00%
Shared risk revenue    
Significant Accounting Policies    
Revenue $ 0 $ 351
Shared risk revenue | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 0.00% 0.00%
Care coordination / management fees    
Significant Accounting Policies    
Revenue $ 8,301 $ 7,924
Care coordination / management fees | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 1.00% 1.00%
Incentive fees    
Significant Accounting Policies    
Revenue $ 573 $ 238
Incentive fees | Revenue | Product Concentration Risk    
Significant Accounting Policies    
Percentage of total revenue (as a percent) 0.00% 0.00%